National Cancer Institute; Notice of Meeting, 7068-7069 [E9-2955]

Download as PDF 7068 Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices level summary reports to monitor each program’s progress in accomplishing goals, and achieving program evaluation and population-based outcomes. OMB approval for the MIS will be requested for a three-year period. Data reported to CDC through the MIS will be used by CDC to identify training and Data will be collected electronically twice per year. The burden per response is expected to decrease after respondents become experienced with entering data and the amount of new data to be entered decreases. There are no costs to respondents other than their time. technical assistance needs, monitor compliance with cooperative agreement requirements, evaluate progress made in achieving program-specific goals, and obtain information needed to respond to Congressional and other inquiries regarding program activities and effectiveness. ESTIMATED ANNUALIZED BURDEN HOURS Respondents Number of respondents Number of responses per respondent Average burden per response (in hours) Total burden (in hours) NCCCP grantees ............................................................................................. 65 2 6 780 Dated: February 4, 2009. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E9–2974 Filed 2–11–09; 8:45 am] BILLING CODE 4163–18–P Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2940 Filed 2–11–09; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P Eunice Kennedy Shriver National Institute of Child Health and Human Development pwalker on PROD1PC71 with NOTICES Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Initial Review Group, Reproduction, Andrology, and Gynecology Subcommittee. Date: March 9, 2009. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Dennis Leszczynski, PhD, Scientific Review Administrator, Division Of Scientific Review, National Institute Of Child Health and Human Development, NIH, 6100 Executive Boulevard, Room 5B01, Bethesda, MD 20892, (301) 435–2717, leszczyd@mail.nih.gov. VerDate Nov<24>2008 17:03 Feb 11, 2009 Jkt 217001 (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Contact Person: Rita Anand, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd Room 5B01, Bethesda, MD 20892, (301) 496–1487, anandr@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2942 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. National Institutes of Health Name of Committee: National Institute of Child Health and Human Development Initial Review Group, Pediatrics Subcommittee. Date: March 19–20, 2009. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: The Legacy Hotel, 1775 Rockville Pike, Rockville, MD 20852. Name of Committee: National Cancer Institute Director’s Consumer Liaison Group. Date: March 26–27, 2009. Time: March 26, 2009, 8:30 a.m. to 4 p.m. Agenda: (1) Approval of Minutes and Welcome; (2) Office of Advocacy Relations Update; (3) Advocates in Research Working Group Update and Discussion; (4) PCP Update and Discussion; (5) Approaches to PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 National Cancer Institute; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director’s Consumer Liaison Group. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. E:\FR\FM\12FEN1.SGM 12FEN1 Federal Register / Vol. 74, No. 28 / Thursday, February 12, 2009 / Notices Engaging Advocates in Translational Research. Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San Jacinto at 8th Street, Lonestar Room, Austin, TX 78701. Time: March 26, 2009, 6 p.m. to 8 p.m. Agenda: A public forum to discuss community priorities will be held in conjunction with the meeting at the same location. Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San Jacinto at 8th Street, Lonestar Room, Austin, TX 78701. Time: March 27, 2009, 8:30 a.m. to 4 p.m. Agenda: (6) Discussion of Community Priorities; (7) Discussion of Innovative Advocate Involvement Strategies; (8) Roundtable Evaluation Discussion; (9) Cancer Prevention and Research Institute of Texas Presentation and Discussion; (10) NCI Director’s Update; (11) Past Meeting Topic Follow Up; (12) Public Comment; (13) Action Items and Conclusion. Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San Jacinto at 8th Street, Lonestar Room, Austin, TX 78701. Contact Person: Benjamin Carollo, MPA, Advocacy Relations Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892–2580, 301–496–0307, carollob@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2955 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P pwalker on PROD1PC71 with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as VerDate Nov<24>2008 17:03 Feb 11, 2009 Jkt 217001 amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Bioassays Using Pluripotent Stem Cells. Date: March 2, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Robert Blaine Moore, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7213, Bethesda, MD 20892, 301–594–8394, mooreb@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Communication Systems for MRI Guided Surgery. Date: March 5, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Robert Blaine Moore, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7213, Bethesda, MD 20892, 301–594–8394, mooreb@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; Nanoprobes for Detecting Atherosclerotic Plaques. Date: March 10, 2009. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Robert Blaine Moore, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7213, Bethesda, MD 20892, 301–594–8394, mooreb@nhlbi.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS) PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 7069 Dated: February 5, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–2953 Filed 2–11–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Heart, Lung, and Blood Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; SBIR Topic 45—Iron Chelators to Treat Iron Overload. Date: March 3, 2009. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: William J. Johnson, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7178, Bethesda, MD 20892–7924, 301–435–0725, johnsonwj@nhlbi.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; SBIR Topic 46—Multiplexed Assay Platforms for Protein Biomarkers of Cardiovascular Disease. Date: March 6, 2009. Time: 1 p.m. to 5 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Youngsuk Oh, PhD, Scientific Review Officer, Review Branch/ DERA, National Heart, Lung, and Blood Institute, 6701 Rockledge Drive, Room 7182, Bethesda, MD 20892–7924, 301–435–0277, yoh@mail.nih.gov. Name of Committee: National Heart, Lung, and Blood Institute Special Emphasis Panel; SBIR Topic 48—Developing Novel Anticoagulants and Synthetic Heparins. E:\FR\FM\12FEN1.SGM 12FEN1

Agencies

[Federal Register Volume 74, Number 28 (Thursday, February 12, 2009)]
[Notices]
[Pages 7068-7069]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-2955]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Cancer Institute Director's Consumer Liaison Group.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Director's Consumer 
Liaison Group.
    Date: March 26-27, 2009.
    Time: March 26, 2009, 8:30 a.m. to 4 p.m.
    Agenda: (1) Approval of Minutes and Welcome; (2) Office of 
Advocacy Relations Update; (3) Advocates in Research Working Group 
Update and Discussion; (4) PCP Update and Discussion; (5) Approaches 
to

[[Page 7069]]

Engaging Advocates in Translational Research.
    Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San 
Jacinto at 8th Street, Lonestar Room, Austin, TX 78701.
    Time: March 26, 2009, 6 p.m. to 8 p.m.
    Agenda: A public forum to discuss community priorities will be 
held in conjunction with the meeting at the same location.
    Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San 
Jacinto at 8th Street, Lonestar Room, Austin, TX 78701.
    Time: March 27, 2009, 8:30 a.m. to 4 p.m.
    Agenda: (6) Discussion of Community Priorities; (7) Discussion 
of Innovative Advocate Involvement Strategies; (8) Roundtable 
Evaluation Discussion; (9) Cancer Prevention and Research Institute 
of Texas Presentation and Discussion; (10) NCI Director's Update; 
(11) Past Meeting Topic Follow Up; (12) Public Comment; (13) Action 
Items and Conclusion.
    Place: Omni Austin Hotel Downtown, Omni Austin Hotel, 700 San 
Jacinto at 8th Street, Lonestar Room, Austin, TX 78701.
    Contact Person: Benjamin Carollo, MPA, Advocacy Relations 
Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 
Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, 
Bethesda, MD 20892-2580, 301-496-0307, carollob@mail.nih.gov. 
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: deainfo.nci.nih.gov/advisory/dclg/dclg.htm, where an agenda 
and any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


    Dated: February 5, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
 [FR Doc. E9-2955 Filed 2-11-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.